IL6 and cancer: Previous studies have shown that high levels of IL-6 in the TME of highly invasive breast cancer and hepatocellular carcinoma (HCC) have a positive effect on cancer cell growth and metastasis, as well as on the attenuation of natural killer (NK) cell immune surveillance [10,11,12].